Читати книгу - "Книжка для дорослих: Як старшати, але не старіти, Дарка Озерна"

98 Kano. M., et al. “Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome”. Scientific Reports, vol. 7, no. 1, 2017, article 12425, https://cutt.ly/phuKbcV

99 Chatoo, M., et al. “Involvement of Corticotropin-Releasing Factor and Receptors in Immune Cells in Irritable Bowel Syndrome”. Frontiers in Endocrinology, vol. 9, no. 21, 2018, https://cutt.ly/ahuKImE

100 Subramaniyam, S., et al. “Oral Phyto-thymol ameliorates the stress induced IBS symptoms”. Scientific Reports, vol. 10, no. 1, 2020, article 13900, https://cutt.ly/OhuKN3E

101 Stanculete, M.F. “Psychiatric Comorbidities in Irritable Bowel Syndrome (IBS)”. Irritable Bowel Syndrome, edited by Chaban, V., IntechOpen, 14 Dec 2016, https://cutt.ly/chIeq5Z

102 Stasi, C., et al. “Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome”. Techniques in Coloproctology, vol. 18, no. 7, 2014, pp. 613–621, https://cutt.ly/oho4mLF

103 Fond, G., et al. “Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis”. European Archives of Psychiatry and Clinical Neuroscience, vol. 264, no. 8, 2014, pp. 651–660, https://cutt.ly/lhpurL7

104 Cunha, J.P. “Low FODMAP Diet for IBS: List of Foods to Eat and Avoid”. MedicineNet, 18 Jul 2019, https://cutt.ly/LhpuShX

105 Barbara, G., et al. “Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome”. Gastroenterology, vol. 156, no. 1, 2019, pp. 46–58.e7, https://cutt.ly/Ahpoj1c

106 “Irritable Bowel Syndrome (IBS): Prevention”. Cleveland Clinic, 24 Sep 2020, https://cutt.ly/WhpoHmN

107 “Irritable bowel syndrome in adults. Quality standard [QS114]. Quality statement 2: Giving a diagnosis”. National Institute for Health and Care Excellence, 11 Feb 2016, https://cutt.ly/hhpprv2

108 “Irritable Bowel Syndrome”. American College of Gastroenterology, https://cutt.ly/ohppIaW

109 Moayyedi, P., et al. “Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS)”. Journal of the Canadian Association of Gastroenterology, vol. 2, no. 1, 2019, pp. 6–29, https://cutt.ly/fhpawtq

110 Black, T.P., Manolakis, C.S., Palma, J.A.D. “‘Red flag’ evaluation yield in irritable bowel syndrome”. Journal of Gastrointestinal and Liver Diseases, vol. 21, no. 2, 2012, pp. 153–156, https://cutt.ly/UhByEsW

111 “Suspected cancer: recognition and referral. NICE guideline [NG12]. 1 Recommendations organised by site of cancer. 1.5 Gynaecological cancers.” National Institute for Health and Care Excellence, 11 Sep 2020, https://cutt.ly/vhpaSJq

112 “Suspected cancer: recognition and referral. NICE guideline [NG12]. 1.3 Lower gastrointestinal tract cancers.” National Institute for Health and Care Excellence, 11 Sep 2020, https://cutt.ly/DhpswED

113 Bischoff, S.C., et al. “ESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease”. Clinical Nutrition, vol. 39, 2020, pp. 632–653, https://cutt.ly/6hpdinU

114 Fröhlich, E., Wahl, R. “Microbiota and Thyroid Interaction in Health and Disease”. Trends in Endocrinology & Metabolism, vol. 30, no. 8, 2019, pp. 479–490, https://cutt.ly/chpdXNQ

115 Tronko, M., et al. “Chapter 8 – Thyroid Cancer Risk in Ukraine Following the Chernobyl Accident (The Ukrainian–American Cohort Thyroid Study)”. Thyroid Cancer and Nuclear Accidents: Long-Term Aftereffects of Chernobyl and Fukushima, edited by Yamashita, S., Thomas, G., Elsevier Inc., 2017, pp. 77–86, https://cutt.ly/jhpfFZC

116 “Radiation and thyroid cancer: FAQs”. British Thyroid Foundation, https://cutt.ly/4hpgfAK

117 Nunan, D., et al. “Physical activity for treatment of irritable bowel syndrome: Cochrane systematic review”. British Journal of General Practice, vol. 69, suppl. 1, 2019, article bjgp19X703205, https://cutt.ly/khph532

118 Daley, A.J., et al. “The Effects of Exercise upon Symptoms and Quality of Life in Patients Diagnosed with Irritable Bowel Syndrome: A Randomised Controlled Trial”. International Journal of Sports Medicine, vol. 29, no. 9, 2008, pp. 778–782, https://cutt.ly/IhpjI7Z

119 “FODMAP Food List”. IBS Diets, 22 Oct 2020, https://cutt.ly/ahpkj7J

120 Rej, A., et al. “The role of diet in irritable bowel syndrome: implications for dietary advice”. Journal of Internal Medicine, vol. 286, no. 5, 2019, pp. 490–502, https://cutt.ly/Yhpktkz

121 Wu,S., et al. “Evaluating intrinsic and non-intrinsic cancer risk factors”. Nature Communications, vol. 9, 2018, article 3490, https://cutt.ly/RhpkFCq

122 “Family Cancer Syndromes”. American Cancer Society, https://cutt.ly/ahpkBiw

123 “Cirrhosis in over 16s: assessment and management. NICE guideline [NG50]. 1.1 Diagnosis”. National Institute for Health and Care Excellence, 06 Jul 2016, https://cutt.ly/Mhplstb

124 Evans, D.G.R., Ingham, S.L. “Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors”. Application of Clinical Genetics, vol. 6, 2013, pp. 53–61, https://cutt.ly/YhpziSu

125 “Signs and symptoms of cancer”. Cancer Research UK, 30 Oct 2020, https://cutt.ly/6hxUIMd

126 Lewis, J. “Identifying patients with suspected cancer: red flags and referral”. The Pharmaceutical Journal, 16 Oct 2018, https://cutt.ly/IhxUcRl

127 Harrison, C.J., Spencer, R.G., and Shackley, D.C. “Transforming cancer outcomes in England: earlier and faster diagnoses, pathways to success, and empowering alliances”. Journal of Healthcare Leadership, vol. 11, 2019, pp. 1–11, https://cutt.ly/IhxUC1E

128 “Cancer Screening Recommendations from the ACS: A Summary of the 2017 Guidelines”. American Family Physician, vol. 97, no. 3, 2018, pp. 208–210, https://cutt.ly/ThxIPa6

129 “American Cancer Society Guidelines for the Early Detection of Cancer”. American Cancer Society, 30 Jul 2020, https://cutt.ly/ihxOxb2

130 Lahey, B.B. “Public Health Significance of Neuroticism”. American Psychologist, vol. 64, no. 4, May-Jun 2009, pp. 241–256, https://cutt.ly/Ug8smsv

131 Diener, E., Chan, M.Y. “Happy People Live Longer: Subjective Well-Being Contributes to Health and Longevity”. Applied Psychology: Health and Well-Being, vol. 3, no. 1, 2011, pp. 1–43, https://cutt.ly/bg8s0P6

132 Zufferey, V., et al. “Neuroticism, depression, and anxiety traits exacerbate the state of cognitive impairment and hippocampal vulnerability to Alzheimer’s disease”. Alzheimer’s & Dementia : Diagnosis, Assessment & Disease Monitoring, vol. 7, 2017, pp. 107–114, https://cutt.ly/2g8daS0

133 Hankin, B.L. “Personality and depressive symptoms: Stress generation and cognitive vulnerabilities to depression in a prospective daily diary study”. Journal of Social and Clinical Psychology, vol. 29, no. 4, 2010, pp. 369–401, https://cutt.ly/Dg8dcfR

134 World Health Organization. Tackling noncommunicable diseases in Ukraine 2015 – 2019. World Health Organization, 2020, 46 p., https://cutt.ly/og8YJUh

135 Lerner, V., Finkelstein, Y., Witztum, E. “The enigma of Lenin’s (1870–1924) malady”. European Journal of Neurology, vol. 11, 2004, pp. 371–376, https://cutt.ly/dhBav9f

136 Burns, A., Iliffe, S. “Dementia”. BMJ, vol. 338, 14 Feb 2009, pp. 405–409, https://cutt.ly/JhIe4Y8

137 Гузій, О.В. “Паліативна допомога в Україні: що має змінитися”. Український медичний часопис, 19.09.2018, https://cutt.ly/4hItgfa

138 “What Are the Signs of Alzheimer’s Disease?” National Institutes of Aging, National Institutes of Health, 16 May 2017, https://cutt.ly/1hItyPI

139 Mayo